Correlation Between Utah Medical and Cocrystal Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Utah Medical and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Utah Medical Products and Cocrystal Pharma, you can compare the effects of market volatilities on Utah Medical and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and Cocrystal Pharma.

Diversification Opportunities for Utah Medical and Cocrystal Pharma

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Utah and Cocrystal is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Utah Medical i.e., Utah Medical and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Utah Medical and Cocrystal Pharma

Given the investment horizon of 90 days Utah Medical Products is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Utah Medical Products is 6.41 times less risky than Cocrystal Pharma. The stock trades about -0.05 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  175.00  in Cocrystal Pharma on November 3, 2024 and sell it today you would earn a total of  24.00  from holding Cocrystal Pharma or generate 13.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.2%
ValuesDaily Returns

Utah Medical Products  vs.  Cocrystal Pharma

 Performance 
       Timeline  
Utah Medical Products 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Cocrystal Pharma 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cocrystal Pharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental indicators, Cocrystal Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Utah Medical and Cocrystal Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Utah Medical and Cocrystal Pharma

The main advantage of trading using opposite Utah Medical and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.
The idea behind Utah Medical Products and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities